Sanni L A, Thomas S R, Tattam B N, Moore D E, Chaudhri G, Stocker R, Hunt N H
Department of Pathology, University of Sydney, New South Wales, Australia.
Am J Pathol. 1998 Feb;152(2):611-9.
The pathogenesis of human cerebral malaria (CM) remains unresolved. In the most widely used murine model of CM, the presence of T lymphocytes and/or interferon (IFN)-gamma is a prerequisite. IFN-gamma is the key inducer of indoleamine 2,3-dioxygenase (IDO), which is the catalyst of the first, and rate-limiting, step in the metabolism of tryptophan (Trp) along the kynurenine (Kyn) pathway. Quinolinic acid (QA), a product of this pathway, is a neuro-excitotoxin, like glutamic acid (Glu) and aspartic acid (Asp). Kynurenic acid (KA), also produced from the Kyn pathway, antagonizes the neuro-excitotoxic effects of QA, Glu, and Asp. We therefore examined the possible roles of IDO, metabolites of the Kyn pathway, Glu, and Asp in the pathogenesis of fatal murine CM. Plasmodium berghei ANKA infection was studied on days 6 and 7 post-inoculation (p.i.), at which time the mice exhibited cerebral symptoms such as convulsions, ataxia, coma, and a positive Wooly/White sign and died within 24 hours. A model for noncerebral malaria (NCM), P. berghei K173 infection, was also studied on days 6 and 7 and 13 to 17 p.i. to examine whether any changes were a general response to malaria infection. Biochemical analyses were done by high-pressure liquid chromatography and gas chromatography/mass spectrometry/mass spectrometry (GC/MS/MS). IDO activity was low or absent in the brains of uninfected mice and NCM mice (days 6 and 7 p.i.) and was induced strongly in the brains of fatal murine CM mice (days 6 and 7 p.i.) and NCM animals (days 13 to 17 p.i.). This induction was inhibited greatly by administration of dexamethasone, a treatment that also prevented CM symptoms and death. Furthermore, IDO induction was absent in IFN-gamma gene knockout mice, which were also resistant to CM. Brain concentrations of Kyn, 3-hydroxykynurenine, and the neuro-excitotoxin QA were significantly increased in both CM mice on days 6 and 7 p.i. and NCM mice on days 13 to 17 p.i., whereas an increase in the ratio of brain QA to KA occurred only in the CM mice at the time they were exhibiting cerebral symptoms. Brain concentrations of Glu and Asp were significantly decreased in CM and NCM mice (days 13 to 17 p.i.). The results imply that neuro-excitation induced by QA may contribute to the convulsions and neuro-excitatory signs observed in CM.
人类脑型疟疾(CM)的发病机制尚未明确。在最常用的CM小鼠模型中,T淋巴细胞和/或干扰素(IFN)-γ的存在是一个先决条件。IFN-γ是吲哚胺2,3-双加氧酶(IDO)的关键诱导剂,IDO是色氨酸(Trp)沿犬尿氨酸(Kyn)途径代谢的第一步及限速步骤的催化剂。该途径的产物喹啉酸(QA)是一种神经兴奋性毒素,与谷氨酸(Glu)和天冬氨酸(Asp)类似。同样由Kyn途径产生的犬尿喹啉酸(KA)可拮抗QA、Glu和Asp的神经兴奋性毒性作用。因此,我们研究了IDO、Kyn途径的代谢产物、Glu和Asp在致命性小鼠CM发病机制中的可能作用。在接种疟原虫(P. berghei)ANKA后第6天和第7天对小鼠进行研究,此时小鼠出现抽搐、共济失调、昏迷等脑部症状,Wooly/White征呈阳性,并在24小时内死亡。还在接种P. berghei K173后第6天和第7天以及第13至17天对非脑型疟疾(NCM)模型进行研究,以检查是否有任何变化是对疟疾感染的一般反应。通过高压液相色谱和气相色谱/质谱/质谱(GC/MS/MS)进行生化分析。在未感染小鼠和NCM小鼠(接种后第6天和第7天)的脑中,IDO活性较低或不存在,而在致命性小鼠CM小鼠(接种后第6天和第7天)和NCM动物(接种后第13至17天)的脑中,IDO活性被强烈诱导。地塞米松给药可极大地抑制这种诱导,该治疗方法还可预防CM症状和死亡。此外,在IFN-γ基因敲除小鼠中未出现IDO诱导,这些小鼠也对CM具有抗性。在接种后第6天和第7天的CM小鼠以及接种后第13至17天的NCM小鼠中,脑内Kyn、3-羟基犬尿氨酸和神经兴奋性毒素QA的浓度均显著升高,而仅在出现脑部症状时的CM小鼠中,脑内QA与KA的比值升高。在CM和NCM小鼠(接种后第13至17天)中,脑内Glu和Asp的浓度显著降低。结果表明,QA诱导的神经兴奋可能导致CM中观察到的抽搐和神经兴奋体征。